Address: Washington, D.C.: Robert S. Strauss Tower, 2001 K Street, N.W., Washington, DC 20006-1037
Areas of Focus: Antitrust Counseling; Antitrust Litigation; Antitrust Mergers & Acquisitions; Antitrust & International Competition; Health Care Antitrust; Regulatory; Disputes & Investigations; Corporate; Antitrust Policy & Regulation; Cartel Investigations & Criminal Antitrust Prosecutions; EU/UK Competition; Mergers & Acquisitions - Federal Government Review; Sovereign & Government Investors; Joint Ventures & Strategic Alliances
Biography:
Gorav is a skilled antitrust lawyer with hands-on knowledge of agency practice, procedure and personnel. He combines the quantitative analysis of a background in engineering and economics with the persuasive skills of a litigator and nationally ranked intercollegiate debater. Gorav guides clients past antitrust obstacles, providing creative and innovative antitrust analyses, whether in defense of a potential or consummated transaction or as a counselor on the full range of business practices. His work led to his appointment as co-chair of the firm’s Innovation Committee.
Gorav’s practice combines government and private sector experience on behalf of clients in a variety of industries. He handles all phases of merger investigations conducted by the U.S. Department of Justice (DOJ) and the FTC. He has navigated clients through the antitrust aspects of transformative transactions and antitrust litigation, and was a vital member of the team that won Global Competition Review’s antitrust “Matter of the Year” award in 2014.
He focuses in particular on the pharmaceutical and energy industries and has represented large and small pharmaceutical companies under investigation by the FTC for price-fixing, improperly listing patents in the Orange Book , and entering into illegal patent settlements, as well as allegations of business practices designed to unfairly lengthen the life-cycle of branded drugs under the Hatch-Waxman Act. In 2017, Legal 500 US noted his “particular expertise in antitrust issues connected with the pharmaceuticals sector.”
Gorav also has experience in handling antitrust litigation matters. He has assisted in the development of litigation strategy for preliminary injunction hearings and complex commercial litigation. He represents clients that have been targeted in criminal antitrust proceedings, focusing on the plausibility of criminal theories and assessing the likelihood of indictments and convictions.
Prior to joining private practice, Gorav served in the FTC’s Bureau of Competition. He investigated a number of highly publicized transactions, including mergers in the publishing, computer hardware and chemical industries.
Representative Work:
- Serving as lead antitrust counsel in the auction of one of the largest equipment rental companies and its ensuing $1.3 billion sale to the largest company in the industry; led the strategy that resulted in quicker merger clearance than other past transactions in the same industry.
- Representing a network airline carrier in its merger with another network airline carrier.
- Securing unconditional clearance for a leading fossil-fuel producer in the sale of certain assets to a nearby rival.
- Formulating the antitrust strategy to obtain international clearance in the hostile takeover of a large fossil-fuel producer by a leading global producer in the same industry.
- Securing unconditional clearance for a leading integrated pharmaceutical drug pharmacy in its acquisition of the largest specialized nationalized pharmacy in its segment.
Credentials:
Education: J.D., The George Washington University Law School, 1998; B.S., University of Michigan, 1995; B.A., University of Michigan, 1995
Bar Admissions: District of Columbia, 2001; New Jersey, 2000
Court Admissions: U.S.C.A., 11th Circuit
Recognitions:
- Washingtonian , Top Lawyer, Antitrust, 2024.
- The Legal 500 US, Antitrust: Merger Control, 2017-2025; Antitrust: Cartel, 2020; Antitrust: Civil Litigation/Class Actions: Defense, 2022-2023.
Affiliations:
-
Insights:
- 2026 Perspectives in Private Equity: Antitrust, Competition & Cross-Border Investment (March 31, 2026): https://www.akingump.com/en/insights/articles/2026-perspectives-in-private-equity-antitrust-competition-and-cross-border-investment
- FTC Updates HSR Filing Fees and Revises Thresholds for 2026; Minimum Size for Reportable Transactions Increases to $133.9 Million (January 16, 2026): https://www.akingump.com/en/insights/alerts/ftc-updates-hsr-filing-fees-and-revises-thresholds-for-2026-minimum-size-for-reportable-transactions-increases-to-dollar1339-million
- Akin Named Among GCR’s 100 Top Competition Practices (December 1, 2025): https://www.akingump.com/en/insights/awards-and-accolades/akin-named-among-gcrs-100-top-competition-practices
- Transparency In Merger Enforcement: Second Request Timelines Remain High Despite Largely Positive Outcomes in Q3 2025 (October 9, 2025): https://www.akingump.com/en/insights/alerts/transparency-in-merger-enforcement-second-request-timelines-remain-high-despite-largely-positive-outcomes-in-q3-2025
- Akin Advises Stream Data Centers and Stream Realty Partners in Majority Stake Sale to Apollo Funds (August 11, 2025): https://www.akingump.com/en/insights/press-releases/akin-advises-stream-data-centers-and-stream-realty-partners-in-majority-stake-sale-to-apollo-funds
- Akin Advises MRC Global in its $3 Billion Merger with DNOW (June 26, 2025): https://www.akingump.com/en/insights/press-releases/akin-advises-mrc-global-in-its-dollar3-billion-merger-with-dnow
- Akin Advises Nippon Steel Corporation in Its Historic Partnership with United States Steel Corporation (June 20, 2025): https://www.akingump.com/en/insights/press-releases/akin-advises-nippon-steel-corporation-in-its-historic-partnership-with-united-states-steel-corporation
- Akin Secures Top Rankings in The Legal 500 US 2025 (June 12, 2025): https://www.akingump.com/en/insights/awards-and-accolades/akin-secures-top-rankings-in-the-legal-500-us-2025
- The First 100 Days of the New HSR Rules: Assessing the Impact (May 29, 2025 ): https://www.akingump.com/en/insights/alerts/the-first-100-days-of-the-new-hsr-rules-assessing-the-impact
- Transparency In Merger Enforcement: At Least 50% of Investigated Deals Cleared for Takeoff in Q1 2025 (May 27, 2025): https://www.akingump.com/en/insights/alerts/transparency-in-merger-enforcement-at-least-50-of-investigated-deals-cleared-for-takeoff-in-q1-2025
- Transparency In Merger Enforcement: Taking Stock of the Deals That Didn't Bark (March 27, 2025): https://www.akingump.com/en/insights/alerts/transparency-in-merger-enforcement-taking-stock-of-the-deals-that-didnt-bark
- 2025 Perspectives in Private Equity: Antitrust & Competition (February 12, 2025): https://www.akingump.com/en/insights/articles/2025-perspectives-in-private-equity-antitrust-and-competition
/Passle/69038f535e183f94cf091320/SearchServiceImages/2026-01-16-20-58-32-706-696aa678614b200ec47177e0.jpg)